Page last updated: 2024-10-27

flumazenil and Alkalosis

flumazenil has been researched along with Alkalosis in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Alkalosis: A pathological condition that removes acid or adds base to the body fluids.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coto, E1
Rodriguez, J1
Jeck, N1
Alvarez, V1
Stone, R1
Loris, C1
Rodriguez, LM1
Fischbach, M1
Seyberth, HW1
Santos, F1

Other Studies

1 other study available for flumazenil and Alkalosis

ArticleYear
A new mutation (intron 9 +1 G>T) in the SLC12A3 gene is linked to Gitelman syndrome in Gypsies.
    Kidney international, 2004, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Alkalosis; Carrier Proteins; Child; Child, Preschool; Female; Founder Effect; Gen

2004